Author

Theodora Frantzi

Observed name: T. Frantzi

Institution: University General Hospital Attikon

Observed institutions: University of Patras, General University Hospital of Patras, University General Hospital Attikon, Affiliated Hospital of Zunyi Medical College, General Hospital of Laconia

OpenAlex ID: A5083124141

PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors

2020 · Foteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, et al. · Cancers · 15

PIOS ratio: predicting the best response of non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors.

2020 · Foteinos-Ioannis D. Dimitrakopoulos, Achilleas Nikolakopoulos, et al. · Journal of Clinical Oncology · 1

30eP Genitourinary sarcomas: A retrospective analysis of 13 cases from a tertiary referral center in Greece (2020-2025)

2026 · E.D. Zazas, A. Kyriazoglou, et al. · ESMO rare cancers.

EP.01.19 Characteristics of Lung Cancer in Never- and Light-Smokers: A Retrospective Study From Greece

2025 · G. Gomatou, I. Kotsantis, et al. · Journal of Thoracic Oncology

1464eP The genetic heterogeneity of head and neck carcinomas

2025 · A. Pantazopoulos, P. Economopoulou, et al. · Annals of Oncology

Prevalence of pulmonary embolism among post COVID-19 patients underwent CT pulmonary angiography, in comparison to others

2024 · Dimitrios Bouras Soulimas, Georgios Chatzis, et al. · Atherosclerosis

RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)

2021 · Chaido Sirinian, Anastasios D. Papanastasiou, et al. · Genes

RANK-c expression in ER-negative breast cancer cells alters sensitivity to tyrosine kinase inhibitors

2021 · C. Sirinian, A.D. Papanastasiou, et al. · The Breast

Works count: 8

Citation count: 16

H-index: 1

I10-index: 1